Age, sex, smoking history, ECOG-PS, pathological type, brain metastasis, liver metastasis, bone metastasis, lung metastasis, line of treatment, clinical stage, EGFR mutation and PD-L1 TPS in the study protocol groups were not statistically significantly different. Here, EGFR is linked to bone metastasis.